SCHEMBL2888545

SCHEMBL2888545

CC(=N)c1cncc([N+](=O)[O-])c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ GAA P10253 2/20 0.40
▸ PRSS1 P07477 1/20 0.40
▸ PRSS2 P07478 1/20 0.40
▸ PRSS3 P35030 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CACNA1B Q00975 1/20 0.38
▸ APBA1 Q02410 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ CES2 O00748 1/20 0.37
▸ CES1 P23141 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL287220 0.84 ALDH1A1 (0.56) ALDH1A1GAASMN1; SMN2CYP3A4MAPK1
SCHEMBL27191977 0.82 ALDH1A1 (0.42) ALDH1A1GAASMN1; SMN2CYP3A4MAPK1
SCHEMBL30702064 0.82 ALDH1A1 (0.42) ALDH1A1GAASMN1; SMN2CYP3A4MAPK1
SCHEMBL1607866 0.78 TP53 (0.55) ALDH1A1GAASMN1; SMN2CYP3A4MEN1
SCHEMBL940807 0.78 TP53 (0.55) ALDH1A1GAASMN1; SMN2CYP3A4MEN1
SCHEMBL11718597 0.77 GAA (0.48) ALDH1A1GAASMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL11722772 0.76 TP53 (0.53) ALDH1A1GAASMN1; SMN2CYP3A4MEN1
SCHEMBL11722198 0.76 ALDH1A1 (0.56) ALDH1A1GAASMN1; SMN2CYP3A4MEN1
Hydrochloric Acid SCHEMBL11722776 0.76 TP53 (0.53) ALDH1A1GAASMN1; SMN2CYP3A4MEN1
SCHEMBL6086071 0.76 SMN1; SMN2 (0.63) ALDH1A1GAAPRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1906965-B1 AZAINDAZOLE COMPOUNDS AND METHODS OF USE CHEMOCENTRYX INC (US) 2015-05-06 — — EP disclosed
US-8461160-B2 Dihydropyrimidinones HOFFMANN-LA ROCHE, INC. (US) 2013-06-11 — — US disclosed
US-20100286158-A1 DIHYDROPYRIMIDINONES HOFFMANN-LA ROCHE, INC. 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286158-A1 DIHYDROPYRIMIDINONES BACE2, BACE1, PSEN2 ALDH1A1 563/4885GAA 39/4885PRSS1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback